IsoPlexis Corp
NASDAQ:ISO
IsoPlexis Corp
NASDAQ:ISO
Price:
0.7616 USD
Market Closed
Updated:
May 29, 2024
IsoPlexis Corp
Total Equity
|
IsoPlexis Corp
Total Equity Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
IsoPlexis Corp
NASDAQ:ISO
|
Total Equity
$41.3m
|
CAGR 3-Years
6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Total Equity
$45.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
10%
|
CAGR 10-Years
8%
|
|
|
Danaher Corp
NYSE:DHR
|
Total Equity
$53.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Total Equity
-$158.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Agilent Technologies Inc
NYSE:A
|
Total Equity
$6.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Total Equity
$6.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
See Also
What is IsoPlexis Corp's Total Equity?
Total Equity
41.3m
USD
41.3m
USD
Based on the financial report for Dec 31, 2022, IsoPlexis Corp's Total Equity amounts to 41.3m USD.
What is IsoPlexis Corp's Total Equity growth rate?
Total Equity CAGR 3Y
6%
6%
Over the last year, the Total Equity growth was -71%. The average annual Total Equity growth rates for IsoPlexis Corp have been 6% over the past three years .
You don't have any saved screeners yet
